Zullo, L., Buschiazzo, A., Massollo, M., Riondato, M., Democrito, A., Marini, C., et al. (2018). 18F-FDG micro-PET imaging for research investigations in the Octopus vulgaris: applications and future directions in invertebrate neuroscience and tissue regeneration. J. Nucl. Med. Jnu...
The PETABC trial demonstrated superior disease detection capabilities of 18F-FDG PET/CT for patients with stage IIB (T3N0) or III breast cancer. This prospective study randomized patients with locoregionally advanced breast cancer to either 18F-FDG PET/CT or conventional staging with CT and bone ...
To address the first question, improved strategies required for early recognition of responders and nonresponders such as novel imagining techniques like PET [164] and/or MRI may be reevaluated in the context of TN disease. To address the second, several concepts are possible: acknowledgements The...
In conclusion, CD47-targeted mAbs combined with current therapies may be an effective treatment option for hematological malignancies. Furthermore, various studies that are evaluating the clinical efficacies and TEAEs of CD47-targeted mAbs are in progress around the world. Nevertheless,Gilead Sciences, I...
L Zullo,A Buschiazzo,M Massollo,... - 《Journal of Nuclear Medicine》 被引量: 2发表: 2018年 Small-Animal F-18-FDG PET for Research on Octopus vulgaris: Applications and Future Directions in Invertebrate Neuroscience and Tissue Regeneration This study aimed to develop a method of administer ...
older patients with chronic pain should receive analgesics as a standing dose rather than on an as-needed basis in order to ensure adequate concentration of analgesic in serum for continuous pain relief [36,38]. Standing-dose analgesics are particularly important for people with cognitive impairment...
Metastatic HER2 + breast cancer is an expanding area of drug development and research, with three new drugs approved in 2020 alone. While first-line therapy is well-established for metastatic HER2 + breast cancer, the standard of care for second-line therapy will likely be changing soo...
Chia-Yin Chen, Chih-Kai Huang, Shih-Pin Lin, Jin-Lin Han, ... Chun-Pin Lin Pages 2811-2817 Article preview select article Numerical modelling of the effective conductivities of composites with arbitrarily shaped inclusions and highly conducting interface Research articleAbstract only Numerical modelli...
For most cancer patients, PD-1/PD-L1 pathway is not the sole speed-limiting factor of antitumor immunity, and it is insufficient to motivate effective antitumor immune response by blocking PD-1/PD-L1 axis. It has been validated that some combination therapies, including α-PD-1/PD-L1 plus...
37 kinase inhibitors have received FDA approval for treatment of malignancies such as breast and lung cancer. Furthermore, about 150 kinase-targeted drugs are in clinical phase trials, and many kinase-specific inhibitors are in the preclinical stage of drug development. Nevertheless, many factors con...